Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOHN W LINDSEY

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1003846619
CMS profile
226763
Location
HOUSTON, TX

General Payments · PY2018–2024

$107,669.99

  • Reported across 210 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,626.72

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,126.72 34
Consulting Fee $500.00 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
TG THERAPEUTICS, INC. $679.06 10
Amgen Inc. $180.15 2
NOVARTIS PHARMACEUTICALS CORPORATION $169.68 11
Genentech USA, Inc. $157.63 4
Alexion Pharmaceuticals, Inc. $124.98 1
GENZYME CORPORATION $123.45 2
EMD Serono, Inc. $109.01 1
ABBVIE INC. $41.62 2
HOSPIRA, INC. $41.14 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $34,009.80 47
PY2019 $43,159.85 59
PY2020 $2,796.82 5
PY2021 $7,679.92 14
PY2022 $7,025.77 16
PY2023 $11,371.11 34
PY2024 $1,626.72 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $24.64 05/01/2024 Food and Beverage Undisputed 01/23/2026 1104886257 CMS
ABBVIE INC. $16.98 08/09/2024 Food and Beverage Undisputed 01/23/2026 1104886259 CMS
Alexion Pharmaceuticals, Inc. $124.98 08/01/2024 Food and Beverage Undisputed 01/23/2026 1110554314 CMS
Amgen Inc. $142.37 02/29/2024 Food and Beverage Undisputed 01/23/2026 1111635592 CMS
Amgen Inc. $37.78 03/01/2024 Food and Beverage Undisputed 01/23/2026 1111635594 CMS
EMD Serono, Inc. $109.01 10/01/2024 Food and Beverage Undisputed 01/23/2026 1120278054 CMS
Genentech USA, Inc. $24.14 02/14/2024 Food and Beverage Undisputed 01/23/2026 1133035534 CMS
Genentech USA, Inc. $20.26 03/22/2024 Food and Beverage Undisputed 01/23/2026 1133035542 CMS
Genentech USA, Inc. $17.56 05/08/2024 Food and Beverage Undisputed 01/23/2026 1133035538 CMS
Genentech USA, Inc. $95.67 09/18/2024 Food and Beverage Undisputed 01/23/2026 1133035546 CMS
GENZYME CORPORATION $100.68 05/16/2024 Food and Beverage Undisputed 01/23/2026 1139673935 CMS
GENZYME CORPORATION $22.77 10/30/2024 Food and Beverage Undisputed 01/23/2026 1139673977 CMS
HOSPIRA, INC. $21.82 03/26/2024 Food and Beverage Undisputed 01/23/2026 1131317505 CMS
HOSPIRA, INC. $19.32 05/15/2024 Food and Beverage Undisputed 01/23/2026 1131452431 CMS
Novartis Pharmaceuticals Corporation $7.26 03/27/2024 Food and Beverage Undisputed 01/23/2026 1086966872 CMS
Novartis Pharmaceuticals Corporation $2.04 03/27/2024 Food and Beverage Undisputed 01/23/2026 1086966874 CMS
Novartis Pharmaceuticals Corporation $19.24 05/13/2024 Food and Beverage Undisputed 01/23/2026 1086966882 CMS
Novartis Pharmaceuticals Corporation $20.68 06/17/2024 Food and Beverage Undisputed 01/23/2026 1086966884 CMS
Novartis Pharmaceuticals Corporation $2.12 06/17/2024 Food and Beverage Undisputed 01/23/2026 1086966886 CMS
Novartis Pharmaceuticals Corporation $3.70 07/17/2024 Food and Beverage Undisputed 01/23/2026 1086966878 CMS
Novartis Pharmaceuticals Corporation $25.24 07/24/2024 Food and Beverage Undisputed 01/23/2026 1086966880 CMS
Novartis Pharmaceuticals Corporation $17.36 08/21/2024 Food and Beverage Undisputed 01/23/2026 1086966888 CMS
Novartis Pharmaceuticals Corporation $21.99 09/30/2024 Food and Beverage Undisputed 01/23/2026 1086966904 CMS
Novartis Pharmaceuticals Corporation $23.83 11/11/2024 Food and Beverage Undisputed 01/23/2026 1086966906 CMS
Novartis Pharmaceuticals Corporation $26.22 12/11/2024 Food and Beverage Undisputed 01/23/2026 1086966908 CMS
TG Therapeutics, Inc. $21.33 04/10/2024 Food and Beverage Undisputed 01/23/2026 1136869398 CMS
TG Therapeutics, Inc. $17.06 05/09/2024 Food and Beverage Undisputed 01/23/2026 1136869394 CMS
TG Therapeutics, Inc. $23.09 06/06/2024 Food and Beverage Undisputed 01/23/2026 1136869362 CMS
TG Therapeutics, Inc. $20.10 07/16/2024 Food and Beverage Undisputed 01/23/2026 1136869466 CMS
TG Therapeutics, Inc. $500.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 1136869524 CMS
TG Therapeutics, Inc. $18.93 07/24/2024 Food and Beverage Undisputed 01/23/2026 1136869430 CMS
TG Therapeutics, Inc. $18.98 08/13/2024 Food and Beverage Undisputed 01/23/2026 1136869462 CMS
TG Therapeutics, Inc. $20.35 09/19/2024 Food and Beverage Undisputed 01/23/2026 1136869408 CMS
TG Therapeutics, Inc. $21.81 10/16/2024 Food and Beverage Undisputed 01/23/2026 1136869504 CMS
TG Therapeutics, Inc. $17.41 12/11/2024 Food and Beverage Undisputed 01/23/2026 1136869506 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.